NEW YORK (GenomeWeb News) – Caliper Life Sciences yesterday reiterated its expectation of organic 2009 revenue growth of between 4 percent and 7 percent and total revenues of between $125 million and $129 million.

The Hopkinton, Mass.-based firm provided the update during a Customer and Investor Open House at its headquarters, which also was webcast. Company officials said during the event that second-quarter revenues from research and imaging products were tracking ahead of expectations, offsetting weakness in the company's service business.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Technology Review reports that researchers in the US have used CRISPR to modify a number of human embryos.

Plant researchers plan to sequence some 10,000 samples that represent the major plant clades, ScienceInsider reports.

By introducing genes from butterfly peas and Canterbury bells, researchers in Japan have developed a blue chrysanthemum, according to NPR.

In Nature this week: a Danish reference genome, and more.